Stay updated on Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Sign up to get notified when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T22:35:07.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, indicating restricted access to the study details.
    Difference
    18%
    Check dated 2026-09-19T22:28:52.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a new version of the page.
    Difference
    0.1%
    Check dated 2026-08-29T20:28:31.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    A new revision tag indicates the system was updated from v3.6.4 to v3.6.5. This reflects an incremental platform update rather than changes to page content.
    Difference
    0.1%
    Check dated 2026-08-08T17:11:58.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page content remained unchanged. There are no additions or deletions to report.
    Difference
    0.1%
    Check dated 2026-08-01T14:12:32.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page’s revision label advanced from v3.6.3 to v3.6.4, indicating an internal deployment or version update. This update does not reflect changes to the study content displayed on the page.
    Difference
    0.1%
    Check dated 2026-07-25T09:31:09.000Z thumbnail image

Stay in the know with updates to Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.